Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
6,989,161
-
Share change
-
+1,271,906
-
Total reported value
-
$1,017,603,574
-
Put/Call ratio
-
17%
-
Price per share
-
$145.60
-
Number of holders
-
155
-
Value change
-
+$186,505,841
-
Number of buys
-
104
-
Number of sells
-
62
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q2 2016
As of 30 Jun 2016,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,989,161 shares.
The largest 10 holders included
SCHRODER INVESTMENT MANAGEMENT GROUP, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, BlackRock Institutional Trust Company, N.A., NORGES BANK, STATE STREET CORP, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, and Swiss National Bank.
This page lists
155
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.